• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Tumbles 200 Points; Darden Restaurants Posts Upbeat Profit

    9/21/23 2:30:04 PM ET
    $CSCO
    $DRI
    $MURF
    $NIR
    Computer Communications Equipment
    Telecommunications
    Restaurants
    Consumer Discretionary
    Get the next $CSCO alert in real time by email

    U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 200 points on Thursday.

    The Dow traded down 0.58% to 34,239.48 while the NASDAQ fell 1.20% to 13,307.77. The S&P 500 also fell, dropping, 1.07% to 4,354.96.

    Check This Out: McDonald's, Halliburton And 2 Other Stocks Insiders Are Selling

     

    Leading and Lagging Sectors

    Utilities shares fell by just 0.4% on Thursday.

    In trading on Thursday, real estate shares tumbled by 2.5%.

     

    Top Headline

    Darden Restaurants Inc (NYSE:DRI) reported better-than-expected earnings for its first quarter.

    Darden Restaurants reported first-quarter FY24 sales growth of 11.6% year-on-year to $2.73 billion, beating the analyst consensus estimate of $2.71 billion. Adjusted EPS of $1.78 beat the consensus estimate of $1.73.

     

    Equities Trading UP

    Murphy Canyon Acquisition Corp. (NASDAQ:MURF) shares shot up 39% to $17.90. Murphy Canyon Acquisition reported stockholder approval of the proposed combination with Conduit Pharmaceuticals.

    Shares of Near Intelligence, Inc. (NASDAQ:NIR) got a boost, shooting 45% to $0.3030. Near Intelligence said it is a trusted partner of leading global commercial real estate companies seeking high-quality real estate analytics on any location, building or site.

    Splunk Inc. (NASDAQ:SPLK) shares were also up, gaining 21% to $144.82. Cisco Systems, Inc (NASDAQ:CSCO) agreed to acquire Splunk for $157 per share in cash, representing approximately $28 billion in equity value.

     

    Equities Trading DOWN

    Travere Therapeutics, Inc. (NASDAQ:TVTX) shares dropped 41% to $7.55 after the company announced topline two-year confirmatory secondary endpoint results from its head-to-head Phase 3 PROTECT Study of Filspari (sparsentan) in IgA nephropathy (IgAN) versus Sanofi SA's (NASDAQ:SNY) Avapro (irbesartan).

    Shares of QuantaSing Group Limited (NASDAQ:QSG) were down 29% to $2.38.

    Seelos Therapeutics, Inc. (NASDAQ:SEEL) was down, falling 38% to $0.1901 after the company announced a $4.5 million registered direct offering of common stock and warrants to purchase common stock. Guggenheim downgraded Seelos Therapeutics from Buy to Neutral.

    Also Check This Out: Top 4 Health Care Stocks That Should Keep You Up At Night

     

    Commodities

    In commodity news, oil traded up 0.2% to $89.81 while gold traded down 1.4% at $1,940.10.

    Silver traded down 0.4% to $23.73 on Thursday while copper fell 2% to $3.7020.

     

    Euro zone

    European shares closed lower today. The eurozone’s STOXX 600 fell 1.30% London’s FTSE 100 fell 0.69% while Spain’s IBEX 35 Index fell 1% The German DAX fell 1.33% French CAC 40 declined 1.59%, while Italy’s FTSE MIB Index dipped 1.78%.

    The Bank of England maintained its policy interest rate at 5.25% on Sept. 21. Spain's trade deficit shrank to EUR 4.9 billion in July from EUR 6.56 billion in the year-ago month. Construction output in Italy fell by 1.1% year-over-year in July. The manufacturing climate indicator in France climbed to 99 in September versus a revised 97 in a month ago.

     

    Asia Pacific Markets

    Asian markets closed lower on Thursday, with Japan’s Nikkei 225 falling 1.37%, Hong Kong’s Hang Seng Index falling 1.29% and China’s Shanghai Composite Index falling 0.77%. India’s S&P BSE Sensex, meanwhile, declined 0.85%.

    The annual inflation rate in Hong Kong came in at 1.8% in August, remaining at its lowest level in four months. Hong Kong’s current account surplus increased to HKD 47.5 billion in the second quarter from HKD 34.7 billion in the year-ago period. The Hong Kong Monetary Authority kept its base rate unchanged at 5.75%.

     

    Economics

    U.S. initial jobless claims fell by 20,000 to 201,000 in the week ending Sept. 16, recording the lowest reading since late January and compared to market estimates of 225,000.

    The U.S. current account deficit shrank to $212.1 billion in the second quarter from a revised reading of a $214.5 billion gap in the prior period and compared to the market estimates of a $221.0 billion gap.

    The Philadelphia Fed Manufacturing Index declined to -13.5 in September from 12 in the previous month and worse than market expectations of -0.7.

    Existing-home sales in the U.S. fell0.7% from a month ago to an annualized rate of 4.04 million units in August.

    U.S. natural gas supplies rose 64 billion cubic feet last week, the EIA said.

    Now Read This: CrowdStrike Holdings To Rally Over 31%? Here Are 10 Other Analyst Forecasts For Thursday

     

    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 108,530,790 cases with around 1,175,490 deaths. India confirmed a total of at least 44,998,290 cases and 531,930 deaths, while France reported over 40,138,560 COVID-19 cases with 167,640 deaths. In total, there were at least 695,580,070 cases of COVID-19 worldwide with more than 6,918,190 deaths.

    Get the next $CSCO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CSCO
    $DRI
    $MURF
    $NIR

    CompanyDatePrice TargetRatingAnalyst
    Sanofi
    $SNY
    1/27/2026Neutral
    Citigroup
    Cisco Systems Inc.
    $CSCO
    1/26/2026$100.00In-line → Outperform
    Evercore ISI
    Darden Restaurants Inc.
    $DRI
    1/23/2026Hold → Buy
    Melius
    Darden Restaurants Inc.
    $DRI
    1/23/2026$235.00Neutral → Outperform
    Mizuho
    Darden Restaurants Inc.
    $DRI
    1/21/2026Outperform → Mkt Perform
    Raymond James
    Sanofi
    $SNY
    1/16/2026Buy → Neutral
    UBS
    Darden Restaurants Inc.
    $DRI
    1/8/2026$207.00Buy → Hold
    Truist
    Sanofi
    $SNY
    1/6/2026Overweight → Equal Weight
    Barclays
    More analyst ratings

    $CSCO
    $DRI
    $MURF
    $NIR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 28, 2025 - FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors

    For Immediate Release: March 28, 2025 Today, the U.S. Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A or hemophilia B, with or without factor VIII or IX inhibitors (neutralizing antibodies).“Today’s approval of Qfitlia is significant for patients wi

    3/28/25 10:17:55 PM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    February 14, 2025 - FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes

    For Immediate Release: February 14, 2025 Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients with diabetes mellitus. Merilog, a rapid-acting human insulin analog, is the first rapid-acting insulin biosimilar product approved by the FDA. As a rapid-acting insulin, Meri

    2/14/25 3:00:13 PM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SOLIQUA 100/33 issued to SANOFI-AVENTIS US

    Submission status for SANOFI-AVENTIS US's drug SOLIQUA 100/33 (SUPPL-14) with active ingredient INSULIN GLARGINE; LIXISENATIDE has changed to 'Approval' on 11/01/2024. Application Category: BLA, Application Number: 208673, Application Classification:

    11/4/24 4:49:34 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CSCO
    $DRI
    $MURF
    $NIR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Golembiewski Michael Joseph bought $100,222 worth of shares (83,000 units at $1.21), increasing direct ownership by 2,406% to 86,450 units (SEC Form 4)

    4 - SEELOS THERAPEUTICS, INC. (0001017491) (Issuer)

    12/1/23 4:16:44 PM ET
    $SEEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Mehra Raj bought $99,999 worth of shares (75,757 units at $1.32), increasing direct ownership by 69% to 185,142 units (SEC Form 4)

    4 - SEELOS THERAPEUTICS, INC. (0001017491) (Issuer)

    12/1/23 4:16:02 PM ET
    $SEEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CSCO
    $DRI
    $MURF
    $NIR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced that on February 10, 2026, the Compensation Committee of its Board of Directors granted inducement equity grants to ten new employees, consisting of inducement restricted stock units, or RSUs, covering an aggregate of 49,200 shares of its common stock. These inducement RSUs are subject to the terms of Travere's 2018 Equity Incentive Plan ("2018 Plan") but were granted outside of the 2018 Plan and were granted as inducements material to the new employees entering into employment with Travere in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs vest over four years, with 25% of the shares vesting on each anniversary of the gran

    2/11/26 5:00:00 PM ET
    $TVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CISCO REPORTS SECOND QUARTER EARNINGS

    SAN JOSE, Calif., Feb. 11, 2026 /PRNewswire/ --  News Summary: Double-digit top and bottom-line growth exceeding our guidance, with EPS growing faster than revenueRecord revenue of $15.3 billion, up 10% year over year; GAAP EPS of $0.80, up 31% year over year; and Non-GAAP EPS of $1.04, up 11% year over yearGAAP gross margin of 65.0% and Non-GAAP gross margin of 67.5%; GAAP operating margin of 24.6% and Non-GAAP operating margin of 34.6%, both above the high end of our guidance rangeAccelerating, double-digit growth in product orders across all geographies and robust growth ac

    2/11/26 4:05:00 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    Cisco Announces New Silicon One G300, Advanced Systems and Optics to Power and Scale AI Data Centers for the Agentic Era

     New G300-powered Cisco N9000 and 8000 systems, advanced optics and management upgrades deliver hyperscale-level performance, reliability and efficiency for all AI network builders. News Summary: As the AI ecosystem buildout expands beyond hyperscalers, Cisco AI Networking innovations address the critical considerations of the next phase of AI buildouts - increasing energy efficiency, lowering operating costs, and simplifying operations.The Cisco Silicon One G300 102.4 Tbps switch silicon can power gigawatt-scale AI clusters for training, inference, and real-time agentic workloads, while maximizing GPU utilization with a 28% improvement in job completion time.New Cisco N9000 and Cisco 8000,

    2/10/26 3:30:00 AM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    $CSCO
    $DRI
    $MURF
    $NIR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Global Sales Tuszik Oliver covered exercise/tax liability with 3,695 shares, decreasing direct ownership by 2% to 191,745 units (SEC Form 4)

    4 - CISCO SYSTEMS, INC. (0000858877) (Issuer)

    2/11/26 8:44:07 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    SVP & Chief Acctg Officer Wong Maria Victoria covered exercise/tax liability with 1,191 shares, decreasing direct ownership by 4% to 31,037 units (SEC Form 4)

    4 - CISCO SYSTEMS, INC. (0000858877) (Issuer)

    2/11/26 8:46:09 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    EVP, Operations Subaiya Thimaya K. covered exercise/tax liability with 6,736 shares, decreasing direct ownership by 4% to 170,386 units (SEC Form 4)

    4 - CISCO SYSTEMS, INC. (0000858877) (Issuer)

    2/11/26 8:43:28 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    $CSCO
    $DRI
    $MURF
    $NIR
    SEC Filings

    View All

    Cisco Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - CISCO SYSTEMS, INC. (0000858877) (Filer)

    2/11/26 4:07:20 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    SEC Form 13F-HR filed by Sanofi

    13F-HR - Sanofi (0001121404) (Filer)

    2/11/26 8:47:59 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SCHEDULE 13G filed by Darden Restaurants Inc.

    SCHEDULE 13G - DARDEN RESTAURANTS INC (0000940944) (Subject)

    2/10/26 11:19:49 AM ET
    $DRI
    Restaurants
    Consumer Discretionary

    $CSCO
    $DRI
    $MURF
    $NIR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup initiated coverage on Sanofi

    Citigroup initiated coverage of Sanofi with a rating of Neutral

    1/27/26 8:49:24 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cisco upgraded by Evercore ISI with a new price target

    Evercore ISI upgraded Cisco from In-line to Outperform and set a new price target of $100.00

    1/26/26 8:32:07 AM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    Darden Restaurants upgraded by Mizuho with a new price target

    Mizuho upgraded Darden Restaurants from Neutral to Outperform and set a new price target of $235.00

    1/23/26 8:09:53 AM ET
    $DRI
    Restaurants
    Consumer Discretionary

    $CSCO
    $DRI
    $MURF
    $NIR
    Leadership Updates

    Live Leadership Updates

    View All

    ITM Appoints Annette Breunig as Chief People Officer

    Global HR leader to drive ITM's long-term human resources strategy, support organizational development and corporate growth Garching / Munich, Germany, October 13, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced the appointment of Annette Breunig as Chief People Officer (CPO). Ms. Breunig brings over 25 years of HR leadership experience at international pharmaceutical, manufacturing and technology companies, including at Siemens AG (FRA: SIE) and Sanofi (NASDAQ:SNY). At ITM, Ms. Breunig will lead the HR team in shaping strategies that unify the organization to achieve both team and business growth objectives while empowering em

    10/13/25 5:00:00 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sanofi Appoints James Guy as Country Lead, Canada and General Manager, Specialty Care

    TORONTO, June 9, 2025 /CNW/ - Sanofi Canada today announced the appointment of James Guy as Country Lead, Canada and General Manager, Specialty Care. In this role, Guy will lead Sanofi's Canada Country Council, which manages the operations of the company's three business units and functions. Guy will also head the Specialty Care business unit in Canada. James Guy Country Lead, Canada and General Manager, Specialty Care "This is an exciting time in Sanofi's history, with the potential for our promising pipeline to deliver several scientific breakthroughs that can improve healt

    6/9/25 10:00:00 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cisco Joins Stargate UAE Initiative

    Cisco to collaborate with G42, OpenAI, Oracle, NVIDI, and SoftBank Group to power AI innovation and infrastructure development in recently announced UAE-US AI Campus in Abu Dhabi News Summary Cisco to provide networking, security and observability hardware and software solutions for OpenAI workloads, advancing AI infrastructure in the Middle East. Strategic partnership supports the Stargate Project's commitment to safe, broadly distributed AI development and responsible capital stewardship.MOU signed by Cisco's Chair and Chief Executive Officer, Chuck Robbins, together with G42, OpenAI, Oracle, NVIDIA and SoftBank Group.MOU aligns with President Trump's visit to the region last week and comp

    5/22/25 11:26:00 AM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    $CSCO
    $DRI
    $MURF
    $NIR
    Financials

    Live finance-specific insights

    View All

    CISCO REPORTS SECOND QUARTER EARNINGS

    SAN JOSE, Calif., Feb. 11, 2026 /PRNewswire/ --  News Summary: Double-digit top and bottom-line growth exceeding our guidance, with EPS growing faster than revenueRecord revenue of $15.3 billion, up 10% year over year; GAAP EPS of $0.80, up 31% year over year; and Non-GAAP EPS of $1.04, up 11% year over yearGAAP gross margin of 65.0% and Non-GAAP gross margin of 67.5%; GAAP operating margin of 24.6% and Non-GAAP operating margin of 34.6%, both above the high end of our guidance rangeAccelerating, double-digit growth in product orders across all geographies and robust growth ac

    2/11/26 4:05:00 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    Cisco Schedules Conference Call for Q2 Fiscal Year 2026 Financial Results

    SAN JOSE, Calif., Feb. 2, 2026 /PRNewswire/ -- Cisco (NASDAQ:CSCO) has scheduled a conference call for Wednesday, Feb. 11, 2026, at 1:30 PM (PT); 4:30 PM (ET) to announce its second quarter fiscal year 2026 financial results for the period ending Saturday, January 24, 2026. Financial results will be released over PR Newswire via US National and European Financial distribution, after the close of the market on Wednesday, Feb. 11, 2026. Cisco's quarterly earnings press release will be posted at https://newsroom.cisco.com.   Date:                     Wednesday, Feb. 11, 2026 Time

    2/2/26 4:30:00 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    Darden Restaurants Reports Fiscal 2026 Second Quarter Results; Declares Quarterly Dividend; And Updates Fiscal 2026 Financial Outlook

    ORLANDO, Fla., Dec. 18, 2025 /PRNewswire/ -- Darden Restaurants, Inc. (NYSE:DRI) today reported its financial results for the second quarter ended November 23, 2025. Second Quarter 2026 Financial Highlights, Comparisons Versus Same Fiscal Quarter Last Year Total sales increased 7.3% to $3.1 billion, driven by a blended same-restaurant sales1 increase of 4.3% and sales from 30 net new restaurantsSame-restaurant sales:Consolidated Darden1 4.3 % Olive Garden 4.7 % LongHorn Steakhouse 5.9 % Fine Dining 0.8 % Other Business1 3.1 % Reported diluted net earnings per share from continuing operations were $2.03Excluding $0.03 of Chuy's transaction and integration related costs and $0.02 of closed re

    12/18/25 7:00:00 AM ET
    $DRI
    Restaurants
    Consumer Discretionary

    $CSCO
    $DRI
    $MURF
    $NIR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Seelos Therapeutics Inc.

    SC 13G/A - SEELOS THERAPEUTICS, INC. (0001017491) (Subject)

    12/4/24 1:29:12 PM ET
    $SEEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Seelos Therapeutics Inc.

    SC 13G/A - SEELOS THERAPEUTICS, INC. (0001017491) (Subject)

    11/14/24 7:32:44 PM ET
    $SEEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Travere Therapeutics Inc.

    SC 13G/A - Travere Therapeutics, Inc. (0001438533) (Subject)

    11/14/24 5:13:38 PM ET
    $TVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care